Get started
Author

Elisavet Tasouli

Observed names: Charikleia Tasouli Elisavet -, E. Tasouli, Tasouli Elisavet Charikleia
ORCID: 0009-0005-4790-4837
Observed ORCID: 0009-0005-4790-4837
OpenAlex ID: A5021053998
Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein
2023 · Konstantina Iliopoulou, Panagiotis Koufargyris, et al. · Infectious Diseases and Therapy · 20
PDF
An NGS-assisted diagnostic workflow for culture-independent detection of bloodstream pathogens and prediction of antimicrobial resistances in sepsis
2025 · David Pinzauti, Manuele Biazzo, et al. · Frontiers in Cellular and Infection Microbiology · 12
PDF
Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial
2025 · Georgios Tavoulareas, Olga Kontakou-Zoniou, et al. · The Lancet Regional Health - Europe · 10
Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial
2024 · Karolina Akinosoglou, Konstantinos Leventogiannis, et al. · International Journal of Antimicrobial Agents · 10
Diagnostic strategies in adrenal insufficiency
2023 · Vasiliki Siampanopoulou, Elisavet Tasouli, et al. · Current Opinion in Endocrinology Diabetes and Obesity · 8
Magnetic resonance imaging features of hypophysitis in patients with cancer treated with immune checkpoint inhibitors
2025 · Anna Angelousi, Stavroula Asimakopoulou, et al. · Journal of Neuroendocrinology · 4
PDF
New Developments in VHL-Associated Neuroendocrine Neoplasms
2025 · Marina Tsoli, Maria Panagaki, et al. · Current Oncology Reports · 4
Long-term immune and epigenetic dysregulation following COVID-19
2025 · Chrysanthi Sidiropoulou, Garyphallia Poulakou, et al. · Clinical Immunology · 3
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection
2026 · Christos Psarrakis, Nikolaos-Renatos Tziolos, et al. · Cell Reports Medicine · 2
PDF
Cardiovascular events and biochemically negative paragangliomas: a systematic review
2025 · George Tsorbatzoglou, Foteini Thanasoula, et al. · Journal of Hypertension · 2
193P Magnetic resonance imaging features of hypophysitis in cancer patients treated with immune checkpoint inhibitors
2025 · D. Ziogas, A. Angelousi, et al. · Immuno-Oncology Technology
Outcomes of surgical resection for small bowel neuroendocrine tumors: a single-center recent experience
2025 · Elisavet Tasouli, Ambareesh Samant, et al. · Endocrine Abstracts
Author response for "Magnetic Resonance Imaging Features of Hypophysitis in Patients With Cancer Treated With Immune Checkpoint Inhibitors"
2025 · Anna Angelousi, Stavroula Asimakopoulou, et al. · Publons reviews and discussion
1693eP Diagnosis and follow-up of immune-related hypophysitis with magnetic resonance imaging (MRI) of pituitary gland
2025 · D.C. Ziogas, A. Angelousi, et al. · Annals of Oncology
Diagnosis and follow-up of immune-related hypophysitis with MRI of pituitary gland.
2025 · Dimitrios C. Ziogas, Anna Angelousi, et al. · Journal of Clinical Oncology
Immune-related hypophysitis and imaging: a distinct type of hypophysitis?
2025 · Anna Angelousi, Stavroula Asimakopoulou, et al. · Endocrine Abstracts
Clarithromycin adjunct treatment leads to substantial financial savings in community-acquired pneumonia: sub-analysis of the ACCESS trial
2024 · Vasiliki Rapti, Elisavet Tasouli, et al. · Journal of Global Antimicrobial Resistance
Psychometric parameters and quality of life in patients with adrenal tumours
2024 · Tasouli Elisavet Charikleia, Chrysoula Mytareli, et al. · Endocrine Abstracts
Bone disorders in oncological patients treated with Immune-Checkpoint Inhibitors (ICIs)
2024 · Vasiliki Siampanopoulou, Anna Angelousi, et al. · Endocrine Abstracts
Works count: 19
Citation count: 75
H-index: 5
I10-index: 4
Year
Topic
Type